G
Guangxi LiuYao Group Co Ltd
SSE:603368
Guangxi LiuYao Group Co Ltd
SSE:603368
Price:
22.79 CNY
-0.04%
Market Closed
Updated:
May 5, 2024
Guangxi LiuYao Group Co Ltd
Net Income (Common)
|
Guangxi LiuYao Group Co Ltd
Net Income (Common) Peer Comparison
Comparables:
1099
S
601607
600998
C
600511
000963
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
G
|
Guangxi LiuYao Group Co Ltd
SSE:603368
|
Net Income (Common)
¥800.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Net Income (Common)
¥8.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
15%
|
|
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Net Income (Common)
¥3.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Net Income (Common)
¥2.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
12%
|
CAGR 10-Years
17%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Net Income (Common)
¥2.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
18%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Net Income (Common)
¥2.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
17%
|
See Also
What is Guangxi LiuYao Group Co Ltd's Net Income (Common)?
Net Income (Common)
800.8m
CNY
800.8m
CNY
Based on the financial report for Sep 30, 2023, Guangxi LiuYao Group Co Ltd's Net Income (Common) amounts to 800.8m CNY.
What is Guangxi LiuYao Group Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
10%
10%
Over the last year, the Net Income (Common) growth was 25%. The average annual Net Income (Common) growth rates for Guangxi LiuYao Group Co Ltd have been 2% over the past three years , 10% over the past five years .
You don't have any saved screeners yet
